Home > Clinical Trials
Check All Search

Saved trials

RECRUITING
NCT07307170
The Analgesic Efficacy and Safety of Mirogabalin in Patients With Herpes Zoster
750 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (NA)
Herpes Zoster


Mirogabalin


Pain
RECRUITING
NCT05735184
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
420 Enrollment(s)
44 Study location(s)
INTERVENTIONAL (PHASE1)
Acute Myeloid Leukemia


Mixed Lineage Leukemia Gene Mutation


Refractory AML


AML With Mutated NPM1


Acute Myeloid Leukemia Recurrent


Acute Myeloid Leukemia, in Relapse


NPM1 Mutation


KMT2Ar


Myeloid Sarcoma


Nucleophosmin 1-mutated Acute Myeloid Leukemia
RECRUITING
NCT07451431
Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain
78 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Diabetic Peripheral Neuropathic Pain (DPNP)
RECRUITING
NCT05681702
Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI
90 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Artery Disease
NOT_YET_RECRUITING
NCT07454707
Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial
1,204 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE3)
Stroke, Ischemic
NOT_YET_RECRUITING
NCT07454668
Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases
20 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1)
Breast Cancer


HER2-positive Breast Cancer


Brain Metastases


Cancer


Cancer Metastatic
RECRUITING
NCT06916520
Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervention (PROMOTE)
300 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Arterial Disease (CAD)


Percutaneous Coronary Intervention (PCI)
ACTIVE_NOT_RECRUITING
NCT04494425
Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer
866 Enrollment(s)
293 Study location(s)
INTERVENTIONAL (PHASE3)
Advanced or Metastatic Breast Cancer